Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SMARCA4 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
COL4A2 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
IPO5 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
FUCA2 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
RRP15 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
SLC25A43 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
RPS27A - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
LMNB2 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
NUP37 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
UNC93B1 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
AGPS - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
ERGIC2 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
PLEK2 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
BCL7A - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
CNPPD1 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
SLC2A4RG - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
FANCI - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on